Skip to main content

Jerel Davis's Form 4 filing

Repare Therapeutics Inc. (RPTX) · filed Jun 7, 2022

Accession no.
0000899243-22-021345
Filed
Jun 7, 2022
Trade date
Jun 3-6, 2022
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 17 non-derivative transactions and 0 derivative transactions. Open-market sales total $9.19M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Jerel DavisCIK 0001745958Director, 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 3, 2022Common SharesSSaleDisposed−250,000$12.25−$3,062,5002,344,451Indirect
Jun 3, 2022Common SharesSSaleDisposed−438,795$12.25−$5,375,238.751,464,875Indirect
Jun 3, 2022Common SharesSSaleDisposed−13,199$12.25−$161,687.7544,065Indirect
Jun 3, 2022Common SharesSSaleDisposed−14,611$12.25−$178,984.7548,776Indirect
Jun 3, 2022Common SharesSSaleDisposed−33,395$12.25−$409,088.75111,484Indirect
Jun 6, 2022Common SharesJOtherDisposed−614,315$0.00$0850,560Indirect
Jun 6, 2022Common SharesJOtherAcquired+132,692$0.00$0132,692Indirect
Jun 6, 2022Common SharesJOtherDisposed−18,478$0.00$025,587Indirect
Jun 6, 2022Common SharesJOtherAcquired+3,992$0.00$0136,684Indirect
Jun 6, 2022Common SharesJOtherDisposed−20,454$0.00$028,322Indirect
Jun 6, 2022Common SharesJOtherAcquired+4,419$0.00$0141,103Indirect
Jun 6, 2022Common SharesJOtherDisposed−141,103$0.00$00Indirect
Jun 6, 2022Common SharesJOtherAcquired+2,653$0.00$014,429Direct
Jun 6, 2022Common SharesJOtherDisposed−46,753$0.00$064,731Indirect
Jun 6, 2022Common SharesJOtherAcquired+10,099$0.00$010,099Indirect
Jun 6, 2022Common SharesJOtherDisposed−10,099$0.00$00Indirect
Jun 6, 2022Common SharesJOtherAcquired+6,448$0.00$020,877Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)